CLRB - CIK 0001279704
Cellectar Biosciences, Inc. trades as CLRB. This page tracks Cellectar Biosciences, Inc. through 1,001 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| S-1/A | - | 2026-05-29 |
| IPO registration | S-1 | 2026-05-19 |
| PRE 14A | - | 2026-05-18 |
| Major company event | 8-K | 2026-05-18 |
| Major company event | 8-K | 2026-05-14 |
| Quarterly report | 10-Q | 2026-05-14 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
The largest companies sharing Cellectar Biosciences, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Cellectar Biosciences, Inc. reported a net loss of $21.79M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.